{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:19:56Z","timestamp":1790144396513,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021117","name":"Liverpool University Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009032","name":"Pfizer Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011330","name":"Nottingham University Hospitals NHS Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.lanepe.2023.100812","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T17:02:27Z","timestamp":1702314147000},"page":"100812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Pneumococcal serotypes and risk factors in adult community acquired pneumonia 2018\u201320: a multicentre UK cohort study"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6647-4618","authenticated-orcid":false,"given":"Louise","family":"Lansbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0914-0416","authenticated-orcid":false,"given":"Tricia M.","family":"McKeever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Aston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Pick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadsala","family":"Baskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle C.","family":"Edwards-Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Bendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bewick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamira","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9215-0553","authenticated-orcid":false,"given":"David","family":"Litt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyi","family":"Eletu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen L.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman K.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Shen","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lanepe.2023.100812_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100812_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060273","article-title":"Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"Said","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lanepe.2023.100812_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.rmed.2018.02.007","article-title":"Burden of pneumococcal community-acquired pneumonia in adults across Europe: a literature review","volume":"137","author":"Torres","year":"2018","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100812_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00937-20","article-title":"A\u00a0new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral Streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.lanepe.2023.100812_bib5","series-title":"Immunisation against infectious disease \u2013 the green Book","year":"2013"},{"key":"10.1016\/j.lanepe.2023.100812_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eclinm.2018.12.007","article-title":"Effectiveness of 23-valent polysaccharide pneumococcal vaccine and changes in invasive pneumococcal disease incidence from 2000 to 2017 in those aged 65 and over in England and Wales","volume":"6","author":"Djennad","year":"2018","journal-title":"eClinicalMedicine"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100812_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003326","article-title":"Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: a case-control test-negative design study","volume":"17","author":"Lawrence","year":"2020","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100812_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3201\/eid2801.210734","article-title":"Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe","volume":"28","author":"Hanquet","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100812_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanepe.2023.100812_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101271","article-title":"Non-invasive pneumococcal pneumonia due to vaccine serotypes: a systematic review and meta-analysis","volume":"44","author":"Lansbury","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100812_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100812_bib12","doi-asserted-by":"crossref","first-page":"e1489","DOI":"10.1093\/cid\/ciaa1045","article-title":"Safety, tolerability, and immunogenicity of a 20-valent pneumococcal conjugate vaccine (PCV20) in adults 60 to 64 Years of age","volume":"73","author":"Hurley","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100812_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/21645515.2018.1532250","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults \u226565 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"15","author":"Peterson","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100812_bib14","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1183\/09031936.00183614","article-title":"Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia","volume":"45","author":"Rodrigo","year":"2015","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100812_bib15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/thoraxjnl-2015-206780","article-title":"Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and\/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease","volume":"70","author":"Torres","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.lanepe.2023.100812_bib16","volume":"vol. 15","year":"2021"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100812_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149540","article-title":"Cost-effectiveness of vaccinating immunocompetent \u226565 Year olds with the 13-valent pneumococcal conjugate vaccine in England","volume":"11","author":"van Hoek","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lanepe.2023.100812_bib19","doi-asserted-by":"crossref","first-page":"e6879","DOI":"10.1136\/bmj.e6879","article-title":"Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis","volume":"345","author":"Rozenbaum","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.lanepe.2023.100812_bib20","series-title":"Interim JCVI statement on adult pneumococcal vaccination in the UK","year":"2015"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100812_bib21","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/cid\/ciy920","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: a systematic review and meta-analysis of observational studies","volume":"68","author":"Sings","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100812_bib22","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1183\/13993003.01451-2015","article-title":"Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden","volume":"47","author":"Galanis","year":"2016","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100812_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100812_bib24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"Dagan","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"43","key":"10.1016\/j.lanepe.2023.100812_bib25","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1016\/j.vaccine.2019.08.059","article-title":"Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: a systematic review and pooled analysis","volume":"37","author":"McLaughlin","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100812_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007438","article-title":"Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci","volume":"14","author":"Azarian","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.lanepe.2023.100812_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1086648","article-title":"Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016-2018-The ECAPS study","volume":"11","author":"Hansen","year":"2023","journal-title":"Front Public Health"},{"issue":"25","key":"10.1016\/j.lanepe.2023.100812_bib29","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2019.04.087","article-title":"Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia","volume":"37","author":"Isturiz","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100812_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11010070","article-title":"Prevalence of pneumococcal serotypes in community-acquired pneumonia among older adults in Italy: a multicenter cohort study","volume":"11","author":"Orsi","year":"2022","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100812_bib31","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3201\/eid2910.230519","article-title":"Serotype distribution and disease severity in adults hospitalized with Streptococcus pneumoniae infection, Bristol and Bath, UK, 2006-2022","volume":"29","author":"Hyams","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.lanepe.2023.100812_bib32","series-title":"Invasive pneumococcal disease","year":"2018"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100812_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195799","article-title":"Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England","volume":"13","author":"Southern","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100812_bib34","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/infdis\/jiz034","article-title":"Pneumococcal colonization in healthy adult research participants in the conjugate vaccine Era, United Kingdom, 2010-2017","volume":"219","author":"Adler","year":"2019","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100812_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9040259","article-title":"A\u00a0systematic review of studies published between 2016 and 2019 on the effectiveness and efficacy of pneumococcal vaccination on pneumonia and invasive pneumococcal disease in an Elderly population","volume":"9","author":"Berild","year":"2020","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100812_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/14760584.2021.1880328","article-title":"Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence","volume":"20","author":"Niederman","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100812_bib37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/thoraxjnl-2021-217979","article-title":"High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors","volume":"77","author":"Dhoubhadel","year":"2022","journal-title":"Thorax"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776223002314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776223002314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:57:28Z","timestamp":1763009848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776223002314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":35,"alternative-id":["S2666776223002314"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100812","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal serotypes and risk factors in adult community acquired pneumonia 2018\u201320: a multicentre UK cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100812"}}